Ginkgo biloba for cognitive impairment and dementia (Q24241561)

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

A tale of a misnamed eponym: Diogenes syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Interaction between psychological and pharmacological treatment in cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

[Delay in progression of dependency and need of care of dementia patients treated with Ginkgo special extract EGb 761].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Efficacy of Ginkgo biloba in 90 outpatients with cerebral insufficiency caused by old age Results of a placebo-controlled double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Cognitive psychophysiology in nootropic drug research: effects of Ginkgo biloba on event-related potentials (P300) in age-associated memory impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

The Zarit Burden Interview: a new short version and screening version.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

The Gottfries-Bråne-Steen scale: validity, reliability and application in anti-dementia drug trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Ginkgo biloba for cerebral insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Pathological verification of ischemic score in differentiation of dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Development and validation of the geriatric evaluation by relatives rating instrument (GERRI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Development and validation of a geriatric depression screening scale: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

Ginkgo biloba for cognitive impairment and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

A Standardized Memory Scale for Clinical Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

A new rating scale for dementia syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

7 January 2021

Spontaneous hyphema associated with ingestion of Ginkgo biloba extract

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

7 January 2021

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

7 January 2021

Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

7 January 2021

Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB3

7 January 2021

10.1002/14651858.CD003120.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2520574

OpenCitations bibliographic resource ID

2520574

1 reference